3 hours bluebird bio (NASDAQ:BLUE) Research Coverage Started at StockNews.comMarketBeat
StockNews.com assumed coverage on shares of bluebird bio in a report on Thursday. They set a “sell” rating on the stock.
XStockNews.com assumed coverage on shares of bluebird bio in a report on Thursday. They set a “sell” rating on the stock.
X